BPG is committed to discovery and dissemination of knowledge
Prospective Study
©The Author(s) 2026.
World J Gastroenterol. Feb 21, 2026; 32(7): 115876
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.115876
Table 3 Comparisons before and after training
Group A
Group B
χ2 test
Logistic regression model
Linear mixed model
Before training
After training
χ2
P value
OR
95%CI
Effect size
95%CI
P value
H. pylori eradication rates
ITT analysis58.59% (290/495)71.63% (356/497)18.58< 0.0011.7851.370-2.3250.1320.049-0.2140.004
PP analysis81.23% (290/357)88.56% (356/402)8.010.0051.7881.191-2.6840.0790.018-0.1390.012
Standardization rates of H. pylori eradication therapies71.0% (355/500)89.6% (448/500)54.57< 0.0013.5192.490-4.9740.1860.054-0.3120.008
Patient review rate71.4% (357/500)80.4% (402/500)11.070.0011.6431.225-2.2040.0900.031-0.1490.005
Adverse reaction documentation rates for physicians21.0% (103/490)21.2% (104/491)0.000.9511.010.743-1.372-0.001-0.052-0.0510.984


Write to the Help Desk